Acton, MA, United States of America

Shengjin Jin

This inventor holds 5 USPTO granted patents and 6 published patent applications, plus 5 CIPO patents and 2 EPO patents. Top assignee: Immunogen, Inc.. Active years: 2010-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shengjin Jin. Retrieved from https://idiyas.com/inventor/shengjin-jin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 5.0

ph-index = 4

Forward Citations = 89(Granted Patents)


Company Filing History:


Years Active: 2010-2022

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations by Shengjin Jin: Pioneering Drug Conjugate Technologies

Introduction

Shengjin Jin is an accomplished inventor based in Acton, MA, known for his significant contributions to the field of drug conjugates. With a total of five patents to his name, Jin's work focuses on developing processes that enhance the efficacy of therapeutic agents through innovative chemical techniques.

Latest Patents

Jin's latest patents revolve around a "Process for preparing purified drug conjugates." This invention outlines a sophisticated method for creating a cell-binding agent that is chemically coupled to a drug. The patented process involves several critical steps: covalently attaching a linker to the cell-binding agent, performing a purification step, conjugating the drug to the cell-binding agent, and conducting a subsequent purification step. This innovative approach aims to improve the delivery and effectiveness of drug therapies.

Career Highlights

Currently employed at ImmunoGen, Inc., Shengjin Jin has made remarkable strides in the pharmaceutical industry. His work reflects a strong commitment to creating advanced drug delivery systems that have the potential to transform treatment options for various diseases.

Collaborations

Throughout his career, Jin has collaborated with esteemed colleagues, including Yong Dai and Yong Wang. These partnerships have facilitated the exchange of ideas and fostered an environment of innovation that has been instrumental to their projects' success.

Conclusion

Shengjin Jin's inventive contributions, particularly in the realm of drug conjugate processes, underscore his role as a leading figure in pharmaceutical innovation. With ongoing efforts at ImmunoGen, Inc., Jin continues to push the boundaries of medical research, aiming to create more effective therapies for patients in need.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…